ACADVL Deep Sequencing in a Case Study: Beyond the Common c.848T>C Pathogenic Variant
Genes · 2025
DOI: 10.3390/genes16050538 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2025. Verfasst von Francesco Baldo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Maternal and Child Health IRCCS Burlo Garofolo, 34137 Trieste, Italy. Hauptthemen laut MEDLINE: Acyl-CoA Dehydrogenase, Long-Chain, Lipid Metabolism, Inborn Errors, Mitochondrial Diseases, Muscular Diseases. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, through the contribution given to the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste - Italy, Italian Ministry of Health.
Abstract (Originalsprache)
Background
Very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD) is caused by biallelic pathogenic variants in ACADVL (acyl-CoA dehydrogenase very-long-chain), leading to impaired fatty acid oxidation and the accumulation of long-chain acylcarnitine. We report a single case of a two-year-old girl, whose neonatal metabolic screening revealed an acylcarnitine profile suggestive of VLCADD, with residual enzymatic activity of 19.8%.
Methods
We performed ACADVL whole-gene sequencing. We then carried out an in silico analysis of the potential effects of the variants with dedicated tools, assessing splicing, RNA structure, RNA binding factors, and protein structure. We also conducted gene expression analysis.
Results
Genetic testing identified her as compound heterozygous for the pathogenic ACADVL variant (NM_000018.3):c.848T>C, inherited from her mother, and for the two paternal variants, c.-64T>C in the basal promoter and c.957G>A, a synonymous substitution in exon 10. Gene expression analysis revealed reduced ACADVL mRNA levels in the proband’s blood cells but without abnormal isoform production. A decreased expression of the paternal allele carrying the 957A was also observed. Despite this significant reduction in mRNA levels, the underlying mechanism remains unclear.
Conclusions
Although currently healthy, due to the VLCAD residual activity within the range associated with the mild form of the disease, the child might be at potential risk for metabolic decompensation or late-onset VLCADD. Our results indicated an allelic imbalance in mRNA expression and c.957G>A is identified as a hypomorphic allele. This suggests that deep ACADVL sequencing is a valuable tool for correlating genetic variants with enzymatic activity levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Maternal and Child Health IRCCS Burlo Garofolo, 34137 Trieste, Italy.
- Department of Medicine, Surgery and Health Sciences, University of Trieste, 34100 Trieste, Italy.
ORCID-Profile: Francesco Baldo, Luisa Zupin, Andrea Magnolato, Valeria Capaci, Maria Teresa Bonati
Förderung
- Italian Ministry of Health, through the contribution given to the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste - Italy
- Italian Ministry of Health
Zitieren
APA
Baldo, F., Zupin, L., Magnolato, A., Capaci, V., & Bonati, M. T. (2025). ACADVL Deep Sequencing in a Case Study: Beyond the Common c.848T>C Pathogenic Variant. Genes. https://doi.org/10.3390/genes16050538
Vancouver
Baldo F, Zupin L, Magnolato A, Capaci V, Bonati MT. ACADVL Deep Sequencing in a Case Study: Beyond the Common c.848T>C Pathogenic Variant. Genes. 2025. doi:10.3390/genes16050538
BibTeX
@article{Baldo2025,
author = {Baldo, Francesco and Zupin, Luisa and Magnolato, Andrea and Capaci, Valeria and Bonati, Maria Teresa},
title = {ACADVL Deep Sequencing in a Case Study: Beyond the Common c.848T>C Pathogenic Variant},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16050538}
}
EUVIMED